Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
26.04.2016 22:23:38

Edwards Lifesciences Corp. Earnings Climb 23% In Q1

(RTTNews) - Edwards Lifesciences Corp. (EW) revealed a profit for its first quarter that advanced compared to the same period last year.

The company said its bottom line advanced to $153.6 million, or $0.71 per share. This was higher than $125.0 million, or $0.57 per share, in last year's first quarter.

Analysts had expected the company to earn $0.66 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 18.1% to $697.3 million. This was up from $590.3 million last year.

Edwards Lifesciences Corp. earnings at a glance:

-Earnings (Q1): $153.6 Mln. vs. $125.0 Mln. last year. -Earnings Growth (Y-o-Y): 22.9% -EPS (Q1): $0.71 vs. $0.57 last year. -EPS Growth (Y-o-Y): 24.6% -Analysts Estimate: $0.66 -Revenue (Q1): $697.3 Mln vs. $590.3 Mln last year. -Revenue Change (Y-o-Y): 18.1%

-Guidance: Next quarter EPS guidance: $0.67 - $0.73 Next quarter revenue guidance: $700 - $740 Mln Full year EPS guidance: $2.67 - $2.77 Full year revenue guidance: $2.7 - $3.0 Bln

Analysen zu Edwards Lifesciences Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Edwards Lifesciences Corp. 67,68 -0,72% Edwards Lifesciences Corp.